Regulations.gov document
Attachment 5 Evidence-based guideline update: Pharmacologic treatment for episodic…
Supporting & Related Material · FDA-2018-P-3372 · posted Sep 6, 2018
Key facts
| Document ID | FDA-2018-P-3372-0007 |
|---|---|
| Title | Attachment 5 Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Re: Citizen Petition from Ohio State University |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2018-P-3372 |
| Posted | Sep 6, 2018 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: